San Diego, CA, United States of America

Mark J Suto


Average Co-Inventor Count = 2.4

ph-index = 12

Forward Citations = 431(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (1987 - 1993)
  • Whitmore Lake, MI (US) (1991 - 1994)
  • San Deigo, CA (US) (1998)
  • La Jolla, CA (US) (1999 - 2000)
  • San Diego, CA (US) (1994 - 2001)

Company Filing History:


Years Active: 1987-2001

Loading Chart...
31 patents (USPTO):Explore Patents

Title: Mark J Suto: Pioneering Innovator in Cytokine Restraining Agents

Introduction:

Meet Mark J Suto, a seasoned inventor and researcher hailing from San Diego, CA. With an impressive collection of 31 patents under his belt, Suto has made significant contributions to the field of pharmaceuticals, particularly in the areas of cytokine restraining agents and anti-inflammatory compounds. This article delves into Suto's latest patents, career highlights, key collaborations, and his noteworthy achievements in the realm of innovations.

Latest Patents:

Suto's recent patents have focused on cytokine restraining agents and pyridopyrimidine analogs. In his groundbreaking invention, "Cytokine restraining agents," Suto presents novel peptides that effectively limit or control the biological activity of cytokines. This invention not only offers great promise for treating various diseases related to cytokine dysregulation but also encompasses effective pharmaceutical compositions and administration methods for optimal therapeutic outcomes.

Likewise, Suto's patent on "Pyridopyrimidine analogs and related compounds" showcases his proficiency in developing anti-inflammatory agents. These quinazoline-containing compounds hold immense potential in preventing and treating immunoinflammatory and autoimmune diseases. Mark J Suto's innovative contribution in this area highlights his dedication to the advancement of healthcare solutions.

Career Highlights:

Throughout his career, Suto has made significant waves in the pharmaceutical industry. He has worked with renowned companies such as Warner-Lambert Company and Signal Pharmaceuticals, Inc. (now Celgene Corporation). During his tenure with these organizations, Suto played a pivotal role in conceptualizing and developing ground-breaking medical advancements.

Collaborations:

Suto's collaborations with esteemed professionals have further amplified his achievements. One notable collaborator was William R Turner, whose contributions have complemented Suto's pioneering work. Together, they have propelled the development and implementation of novel patents and inventions. Another esteemed colleague of Suto's is Beverly E Girten, whose collective efforts have undoubtedly enhanced the impact of their research.

Conclusion:

Mark J Suto, a prominent innovator with a distinguished career, has cemented his name in the field of pharmaceuticals, particularly in the domain of cytokine restraining agents and anti-inflammatory compounds. With an impressive portfolio of 31 patents, Suto's inventions promise to shape the future of healthcare by offering new avenues for treating cytokine dysregulation and combating immunoinflammatory diseases.

His relentless pursuit of innovative solutions, coupled with his collaborations with esteemed colleagues, demonstrates Suto's commitment to advancing medical science. As his research continues to inspire new avenues of exploration, the impact of Mark J Suto's work will undoubtedly be felt in the field of pharmaceutical innovations for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…